UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Collaborative Payer Provider Model Enhances Primary Care, Producing Triple Aim Plus One Outcomes: A Cohort Study

Healthcare (Basel), 2017-08, Vol.5 (3), p.48

2017

Volltextzugriff (PDF)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.781-794

2019

Volltextzugriff (PDF)

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Blood, 2022-11, Vol.140 (Supplement 1), p.9491-9492

2022

Volltextzugriff (PDF)

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.5058-5059

2022

Volltextzugriff (PDF)

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

Blood, 2020-11, Vol.136 (Supplement 1), p.2-3

2020

Volltextzugriff (PDF)

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8504-8504

2020

Volltextzugriff (PDF)

MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS8610-TPS8610

2015

Volltextzugriff (PDF)

ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S379

2022

Volltextzugriff (PDF)

Poster: ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S164

2022

Volltextzugriff (PDF)

Pomalidomide (POM), bortezomib, and low‐dose dexamethasone (PVd) vs bortezomib and low-dose dexamethasone (Vd) in lenalidomide (LEN)-exposed patients (pts) with relapsed or refractory multiple myeloma (RRMM): Phase 3 OPTIMISMM trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.8001-8001

2018

Volltextzugriff (PDF)

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

Blood, 2014-12, Vol.124 (21), p.4730-4730

2014

Volltextzugriff (PDF)

MM-004: A Phase 1, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination with Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma in Japan

Blood, 2014-12, Vol.124 (21), p.2107-2107

2014

Volltextzugriff (PDF)

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

Blood, 2015-12, Vol.126 (23), p.5374-5374

2015

Volltextzugriff (PDF)

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions

Aerospace science and technology, 2002-11, Vol.6 (7), p.495-506

2002

Volltextzugriff (PDF)

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability Of Pomalidomide + Low-Dose Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment

Blood, 2013-11, Vol.122 (21), p.5393-5393

2013

Volltextzugriff (PDF)

A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial

Experimental hematology & oncology, 2016-04, Vol.5 (11), p.11-11, Article 11

2016

Volltextzugriff (PDF)

Incidence of atrial rhythm disturbances is a function of AV-delay, not of lower rate limit

Heart rhythm, 2005-05, Vol.2 (5), p.S322-S323

2005

Volltextzugriff (PDF)

Neue Strukturen für das Hochschulsystem in China: Akademikerarbeitslosigkeit versus Fachkräftemangel

Forschung & Lehre (Bonn), 2015, Vol.22 (10), p.838-840

Schmidt-Dörr, Thomas

2015

Volltextzugriff (PDF)

Studieren in China: Gaokao oder Auslandsstudium?

Forschung & Lehre (Bonn), 2014, Vol.21 (11), p.906-907

Schmidt-Dörr, Thomas

2014

Volltextzugriff (PDF)

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions: Combustion

Aerospace science and technology, 2002, Vol.6 (7), p.495-506

2002

Volltextzugriff (PDF)

Software guides error-free assembly. (computer-aided design software)

Machine design, 1998-03, Vol.70 (5), p.46-47

Doerr, Thomas

1998

Volltextzugriff (PDF)

Ein Beitrag zur Reduzierung des Stickoxydausstosses von Gasturbinenbrennkammern : die Optimierung des Mischungsprozesses der Fett-Mager-Stufenverbrennung

Dorr, Thomas

1995

Volltextzugriff (PDF)

AN ANALYSIS OF ERRORS IN THE ALGEBRAIC RECONSTRUCTION TECHNIQUE WITH AN APPLICATION TO GEOTOMOGRAPHY

DOERR, THOMAS ANTHONY

1983

Volltextzugriff (PDF)

Unterstützung der spontanen atrioventrukulären Überleitung bei Patienten mit DDD(R)-Schrittmachern Effektivität und Sicherheit: Effektivität und Sicherheit

Herz, 2001-02, Vol.26 (1), p.69-74

2001

Volltextzugriff (PDF)

Schwarze Fahne

DUZ : Das unabhängige Hochschulmagazin, 1998, Vol.54 (8), p.18-19

Schmidt-Dörr, Thomas

1998

Volltextzugriff (PDF)

1 – 25 von 655

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(606)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Computer Science
(71)
Technology
(67)
Life Sciences & Biomedicine
(52)
Physical Sciences
(32)
Computer Science, Theory & Methods
(25)
Engineering
(23)
Neural And Evolutionary Computing
(22)
Computer Science, Artificial Intelligence
(18)
Evolutionary Computation
(15)
Mathematics
(14)
Artificial Intelligence
(13)
Evolutionary Algorithms
(12)
Multi-Objective Optimization
(12)
Physics
(12)
Runtime Analysis
(12)
Engineering, Electrical & Electronic
(11)
Animals
(10)
Black-Box Optimization
(10)
Exact Sciences And Technology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

The Collaborative Payer Provider Model Enhances Primary Care, Producing Triple Aim Plus One Outcomes: A Cohort Study

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)

MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM)

ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Poster: ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Pomalidomide (POM), bortezomib, and low‐dose dexamethasone (PVd) vs bortezomib and low-dose dexamethasone (Vd) in lenalidomide (LEN)-exposed patients (pts) with relapsed or refractory multiple myeloma (RRMM): Phase 3 OPTIMISMM trial

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

MM-004: A Phase 1, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination with Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma in Japan

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability Of Pomalidomide + Low-Dose Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment

A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial

Incidence of atrial rhythm disturbances is a function of AV-delay, not of lower rate limit

Neue Strukturen für das Hochschulsystem in China: Akademikerarbeitslosigkeit versus Fachkräftemangel

Studieren in China: Gaokao oder Auslandsstudium?

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions: Combustion

Software guides error-free assembly. (computer-aided design software)

Ein Beitrag zur Reduzierung des Stickoxydausstosses von Gasturbinenbrennkammern : die Optimierung des Mischungsprozesses der Fett-Mager-Stufenverbrennung

AN ANALYSIS OF ERRORS IN THE ALGEBRAIC RECONSTRUCTION TECHNIQUE WITH AN APPLICATION TO GEOTOMOGRAPHY

Unterstützung der spontanen atrioventrukulären Überleitung bei Patienten mit DDD(R)-Schrittmachern Effektivität und Sicherheit: Effektivität und Sicherheit

Schwarze Fahne

Aktive Filter

Suchergebnisse filtern